Yuichiro Shindo

11PUBLICATIONS
46CO-AUTHORS
Patient safetyMedical molecular engineering of nucleic acids and proteinsPredictive and prognostic markersEpidemiological methodsMedical microbiology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Apr 27, 2026
Timing of Remdesivir Initiation and Clinical Outcomes in Hospitalized Patients with COVID-19 Who Are at High Risk of Disease Progression in Japan: A Health Insurance Claims Database Study.

|Jul 30, 2025
Adrenomedullin Therapy for Moderate-to-Severe COVID-19 Pneumonia: Double-Blind Placebo-Controlled Phase 2a Trial.

Toshihiro Kita, Norio Ohmagari, Sho Saito

|Mar 28, 2025
Influence of Educational Films on Antiviral Prescription for COVID-19: Insights from Web-Based Survey in Japan.

Kosaku Komiya, Akihiko Hagiwara, Yuichiro Shindo

|Nov 27, 2024
Impact of Education on Inappropriate Antibiotic Prescription for Respiratory Tract Infection Based on Physicians' Justifications: A Web-Based Survey in Japan.

Ryohei Kudoh, Kosaku Komiya, Norihito Kaku

|Dec 14, 2022
Identification of two specific transcriptomic clusters of COVID-19 acute respiratory distress syndrome patients with different immune profiles and different outcomes.

Yuichiro Shindo, Charles S Dela Cruz, Martin Witzenrath

|Sep 21, 2021
The Mystery of Futility of Appropriate Antibiotics for Coinfection in COVID-19.

Daisuke Kasugai, Naruhiro Jingushi, Norihiro Omote

Pageof 2

Frequent Collaborators

3 joint publications

Kosaku Komiya

2 joint publications

Keisuke Tomii

2 joint publications

Takahiro Takazono

1 joint publications

Mark Berry